Showing results (1-10 of 909) with videos related to
Sort By:
Pageof 91
The Prostate|March 22, 2000
Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patientsG P Murphy, B A Tjoa, S J Simmons, et al.The Prostate|September 1, 1997
Transrectal ultrasound microbubble contrast angiography of the prostateH Ragde, G M Kenny, G P Murphy, et al.The Prostate|February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapyG P Murphy, A A Elgamal, M J Troychak, et al.The Prostate|February 11, 1999
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic diseaseG P Murphy, B A Tjoa, S J Simmons, et al.The Prostate|March 1, 1995
Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargementG P Murphy, E H Holmes, A L Boynton, et al.The Prostate|October 1, 1994
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patientsY P Rochon, J S Horoszewicz, A L Boynton, et al.The Prostate|July 1, 1999
Follow-up evaluation of a phase II prostate cancer vaccine trialB A Tjoa, S J Simmons, A Elgamal, et al.The Prostate|May 27, 1999
GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialS J Simmons, B A Tjoa, M Rogers, et al.Progress in Clinical and Biological Research|January 1, 1988
Management of metastatic prostatic cancerG P MurphyPageof 91